Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,276 | -43,924 | -14,277 | -10,003 | -5,362 |
| Depreciation Amortization | 71 | 672 | 580 | 438 | 222 |
| Income taxes - deferred | N/A | -7,962 | N/A | N/A | N/A |
| Accounts receivable | 84 | 24 | 183 | 148 | 45 |
| Other Working Capital | -904 | 1,920 | 852 | 978 | 1,920 |
| Other Operating Activity | -13 | 33,399 | -104 | -46 | -145 |
| Operating Cash Flow | $-4,037 | $-15,871 | $-12,766 | $-8,485 | $-3,320 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | 72 | 72 | -3 | -3 |
| Purchase Of Investment | -299 | -7,256 | -7,256 | -7,256 | -3,199 |
| Sale Of Investment | 1,372 | 29,390 | 17,011 | 14,011 | 6,124 |
| Investing Cash Flow | $1,070 | $22,207 | $9,828 | $6,753 | $2,922 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 9,996 | 3,661 | 3,661 | 3,661 | 3,661 |
| End Cash Position | 7,028 | 9,996 | 722 | 1,928 | 3,263 |
| Net Cash Flow | $-2,968 | $6,336 | $-2,938 | $-1,732 | $-398 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,037 | -15,871 | -12,766 | -8,485 | -3,320 |
| Capital Expenditure | -3 | -3 | -3 | -3 | -3 |
| Free Cash Flow | -4,041 | -15,874 | -12,769 | -8,488 | -3,323 |